THE AFFILIATED HOSPITAL OF QINGDAO UNIVERSITY
🇨🇳China
Remote Blood Pressure Management Clinical Application Research
Not Applicable
- Conditions
- Hypertension
- Interventions
- Device: Ordinary household electronic sphygmomanometerDevice: Office electronic sphygmomanometerDevice: Electronic remote blood pressure monitor
- First Posted Date
- 2020-12-30
- Last Posted Date
- 2022-02-17
- Lead Sponsor
- The Affiliated Hospital of Qingdao University
- Target Recruit Count
- 1050
- Registration Number
- NCT04690478
- Locations
- 🇨🇳
Remote electronic sphygmomanometer, Qingdao, Shandong, China
The Combination of Anlotinib and Immune Checkpoint Inhibitors for Advanced NSCLC Patients With Muti-line Therapy
Phase 1
Completed
- Conditions
- NSCLCAngiogenesisImmunotherapy
- Interventions
- First Posted Date
- 2020-12-17
- Last Posted Date
- 2020-12-17
- Lead Sponsor
- The Affiliated Hospital of Qingdao University
- Target Recruit Count
- 30
- Registration Number
- NCT04670107
- Locations
- 🇨🇳
The Affiliated Hospital of Qingdao University, Qingdao, China
Gastrointestinal Surgery Study Group 2001
Not Applicable
- Conditions
- Computed Tomography AngiographyClinical OutcomeGastrostomy
- Interventions
- Device: CT angiography（CTA）
- First Posted Date
- 2020-11-19
- Last Posted Date
- 2020-12-09
- Lead Sponsor
- The Affiliated Hospital of Qingdao University
- Target Recruit Count
- 382
- Registration Number
- NCT04636099
- Locations
- 🇨🇳
Department of Gastrointestinal Surgery, Qingdao University Affiliated Hospital, Qingdao, Shandong, China
Efficacy and Safety of Clinical Telesurgery Using Chinese Independently Developed Surgical Robot System
Not Applicable
Completed
- Conditions
- Adrenal TumorRenal Cell CarcinomaBladder Cancer
- Interventions
- Procedure: adrenalectomy for adrenal adenoma
- First Posted Date
- 2020-09-30
- Last Posted Date
- 2022-02-16
- Lead Sponsor
- The Affiliated Hospital of Qingdao University
- Target Recruit Count
- 1
- Registration Number
- NCT04570176
- Locations
- 🇨🇳
The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
Bioequivalence of Oral Formulations of Anastrozole in Healthy Chinese Volunteers Under Fed Condition
Phase 1
- Conditions
- Healthy Volunteers
- Interventions
- Drug: test-anastrozole tablet (Salutas Pharma GmbH)Drug: reference-anastrozole tablet
- First Posted Date
- 2020-06-24
- Last Posted Date
- 2020-06-30
- Lead Sponsor
- The Affiliated Hospital of Qingdao University
- Target Recruit Count
- 26
- Registration Number
- NCT04445922
- Locations
- 🇨🇳
Phase I Clinical Research Center, Qingdao, Shandong, China
Bioequivalence of Oral Formulations of Anastrozole in Healthy Chinese Volunteers Under Fasted Condition
Phase 1
- Conditions
- Healthy Volunteers
- Interventions
- Drug: test-anastrozole tablet (Salutas Pharma GmbH)Drug: reference-anastrozole tablet (Arimidex)
- First Posted Date
- 2020-06-19
- Last Posted Date
- 2020-06-30
- Lead Sponsor
- The Affiliated Hospital of Qingdao University
- Target Recruit Count
- 26
- Registration Number
- NCT04438733
- Locations
- 🇨🇳
Phase I Clinical Research Center, Qingdao, Shandong, China
Pharmacokinetics and Bioequivalence of Rivaroxaban Tablet in Healthy Chinese Volunteers
Phase 1
Completed
- Conditions
- Healthy Subjects
- Interventions
- First Posted Date
- 2020-06-11
- Last Posted Date
- 2020-06-11
- Lead Sponsor
- The Affiliated Hospital of Qingdao University
- Target Recruit Count
- 72
- Registration Number
- NCT04424381
- Locations
- 🇨🇳
Phase I Clinical Research Center, Qingdao, Shandong, China
Pharmacokinetic and Safety Comparison of Two Capecitabine Tablets in Patients With Colorectal or Breast Cancer
Phase 1
Completed
- Conditions
- Patient Participation
- Interventions
- Drug: 150 mg of Xeloda®Drug: 150 mg of capecitabine
- First Posted Date
- 2020-06-09
- Last Posted Date
- 2020-06-09
- Lead Sponsor
- The Affiliated Hospital of Qingdao University
- Target Recruit Count
- 48
- Registration Number
- NCT04420871
- Locations
- 🇨🇳
Phase Ⅰ Clinical Research Center, Qingdao, Shandong, China
Bioequivalence of Cefprozil Granule in Healthy Chinese Volunteers
Phase 1
Completed
- Conditions
- Healthy Volunteers
- Interventions
- First Posted Date
- 2020-06-04
- Last Posted Date
- 2020-06-04
- Lead Sponsor
- The Affiliated Hospital of Qingdao University
- Target Recruit Count
- 60
- Registration Number
- NCT04414254
- Locations
- 🇨🇳
Phase I Clinical Research Center, Qingdao, Shandong, China
Bioequivalence of Levamlodipine Besylate Tablets in Healthy Chinese Subjects
Phase 1
Completed
- Conditions
- Healthy Subjects
- Interventions
- First Posted Date
- 2020-06-02
- Last Posted Date
- 2020-06-05
- Lead Sponsor
- The Affiliated Hospital of Qingdao University
- Target Recruit Count
- 48
- Registration Number
- NCT04411875
- Locations
- 🇨🇳
Phase Ⅰ Clinical Research Center, Qingdao, Shandong, China
© Copyright 2025. All Rights Reserved by MedPath